Search
for
Sort by
Research 931–960 of 1000+
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- Overview of the Role of 308 Monochromatic Excimer Phototherapy for the Treatment of Alopecia Areata
- "Oral PEY Treatment Induces Hair Regrowth and Improves Hair Quality in Patients with Alopecia"
- 5-Alpha-Reductase Inhibitor Treatment for Frontal Fibrosing Alopecia:A Myth or Truth?
- Add-on effect of plum-blossom needling in alopecia areata: a qualitative evidence synthesis
- Topical calcipotriol mixed with topical steroid versus topical steroid alone in treatment of alopecia areata
- Lesions in the Axilla After Hair Removal Using Intense Pulsed Light
- Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps.
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Fox-Fordyce Disease
- Reviving Hair Naturally: An Ayurvedic Case Report on Indralupta (Alopecia)
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Evaluating Anti-Inflammatory Potential of Platelet-Rich Plasma in Scarring Alopecia: A Systematic Review
- “Downy hair sign”—A clue to autoimmune disease in curly hair
- Management of Indralupta (Alopecia Areata) - A Case Study
- Utility of dermoscopy in alopecia areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Trichoscopic findings of discoid lupus erythematosus alopecia: A cross-sectional study
- A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
- Topical dapsone for folliculitis decalvans: A retrospective cohort study
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Evaluation of utility of phenol in alopecia areata
- Measuring Patient Quality of Life Following Treatment for Alopecia
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis